Filter
40
Filtered Results: 40
Text search:
Global
Laboratory
Initiative
(GLI),
Stop
TB
Partnership
Featured
Recommendations
2
New Publications
12
Language
Document type
No document type
30
Manuals
6
Guidelines
2
Studies & Reports
1
Brochures
1
Countries / Regions
Latin America and the Carribbean
2
Rwanda
1
Cameroon
1
Africa
1
Bangladesh
1
Brazil
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
4
Bacteriology
3
Disease Prevention & Control
2
TB
2
COVID-19
1
Community Health
1
Virology
1
Public Health
1
Policies
1
Health Systems
1
Global Health
1
Toolboxes
Detection & Diagnosis
11
Prevention & Control
6
Laboratory
3
Drug resistant TB
3
Policies & Strategies
2
HIV testing & services
2
Adults
2
Children & Adolescents
2
TB & Other Vulnerable Populations
2
TB/COVID-19
2
Testing Guidelines
2
AmR (Region of Americas)
2
Eastern Europe & Central Asia
2
Biosafety
1
Clinical Aspects, Treatment & Prevention
1
Rwanda
1
Prophylaxis
1
Advocacy
1
Drug resistance
1
Reports
1
Diagnostics & Laboratory Guidance
1
Access to treatment and laboratory
1
Regional Reports & Guidelines, others
1
TB & Prisoners
1
Disease Prevention & Control
1
Research & Access
1
Lobby and Advocacy
1
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Recommended actions and international and national level
Recommended actions at international and national levels
A survey of prevention, testing and treatment policies and practices
This guide includes information relevant for tuberculosis (TB) program and laboratory managers, as well as Ministry of Health officials across disease programs interested in establishing integrated solutions for specimen referral. Though TB-focused in name, it offers integration-oriented assessment,...
Progress in diagnosis: Akey in overcoming the MDR-TB crisis.
The expanse-TV project progress and impact brief.
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
TEchnical Note
WHO Information Leaflet COVID-19: Considerations on tuberculosis (TB) care
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People with TB are usually more vulnerable to other infectio...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
